Cargando…
Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer
BACKGROUND: Men diagnosed with localised prostate cancer (LPC) face difficult choices between treatment options that can cause persistent problems with sexual, urinary and bowel function. Controlled trial evidence about the survival benefits of the full range of treatment alternatives is limited, an...
Autores principales: | King, M T, Viney, R, Smith, D P, Hossain, I, Street, D, Savage, E, Fowler, S, Berry, M P, Stockler, M, Cozzi, P, Stricker, P, Ward, J, Armstrong, B K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324299/ https://www.ncbi.nlm.nih.gov/pubmed/22274410 http://dx.doi.org/10.1038/bjc.2011.552 |
Ejemplares similares
-
Quality of life three years after diagnosis of localised prostate cancer: population based cohort study
por: Smith, David P, et al.
Publicado: (2009) -
Localisation of beam offset jitter sources at ATF2
por: Pfingstner, J, et al.
Publicado: (2014) -
Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
por: Abdelmoumene, N., et al.
Publicado: (1994) -
Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)
por: Scheinberg, Tahlia, et al.
Publicado: (2020) -
Studies of wire offset effects on gas gain in the ATLAS TRT straw chamber
por: Cwetanski, Peter, et al.
Publicado: (2000)